Evaluating the effectiveness of lateral postural management for breech presentation: study protocol for a randomized controlled trial (BRLT study)
DiscussionThis trial will answer whether the lateral positioning technique is effective in treating breech presentation and, depending on the results, may provide a very simple, less painful, and safe option for treating breech presentation before 36 weeks, and it may impact breech presentation treatment.Trial registrationUMIN Clinical Trials Registry UMIN000043613. Registered on 15 March 2021https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049800. (Source: Trials)
Source: Trials - May 27, 2023 Category: Research Source Type: clinical trials
A Phase 1 Trial to Investigate Bioequivalence Between 5 × 10 mg Tablets and 2 × 25 mg Tablets of Daridorexant in Healthy Male and Female Japanese Participants
Condition: Healthy Interventions: Drug: Daridorexant 10 mg; Drug: Daridorexant 25 mg Sponsor: Idorsia Pharmaceuticals Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 26, 2023 Category: Research Source Type: clinical trials
WONDER-01: immediate necrosectomy vs. drainage-oriented step-up approach after endoscopic ultrasound-guided drainage of walled-off necrosis —study protocol for a multicentre randomised controlled trial
DiscussionThe WONDER-01 trial will investigate the efficacy and safety of immediate DEN compared to the step-up approach for WON patients receiving EUS-guided treatment. The findings will help us to establish new treatment standards for patients with symptomatic WON.Trial registrationClinicalTrials.gov NCT05451901, registered on 11 July 2022. UMIN000048310, registered on 7 July 2022. jRCT1032220055, registered on 1 May 2022. (Source: Trials)
Source: Trials - May 24, 2023 Category: Research Source Type: clinical trials
A Research Study of a New Medicine NNC0519-0130 in Japanese and Non-Japanese Men
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: NNC0519-0130; Drug: Placebo Sponsor: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 23, 2023 Category: Research Source Type: clinical trials
fNIRS Neurofeedback in Highly Impulsive Participants With ROI Regions DLPFC and IFG
Condition: Impulsivity Intervention: Device: fNIRS-Neurofeedback Sponsors: University Hospital Tuebingen; Japan society for the promotion of science; Nakatani foundation and Japan foundation for pediatric research Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 17, 2023 Category: Research Source Type: clinical trials
